Genentech opens new $250M biologics manufacturing site in South San Francisco

While Genentech and Roche have been on the hunt for cancer therapies, they’ve also been investing in new construction. The company announced on Tuesday that it has opened the doors to its new $250 million manufacturing site for small-batch biologics in South San Francisco. The site, called the “Clinical Supply…

...

Click to view original post